+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 1iil | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 | ||||||
要素 |
| ||||||
キーワード | GROWTH FACTOR/GROWTH FACTOR RECEPTOR / IMMUNOGLOBULIN LIKE DOMAIN / B-TREFOIL / GROWTH FACTOR-GROWTH FACTOR RECEPTOR COMPLEX | ||||||
| 機能・相同性 | 機能・相同性情報growth factor dependent regulation of skeletal muscle satellite cell proliferation / positive regulation of inner ear auditory receptor cell differentiation / positive regulation of neuroepithelial cell differentiation / regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / response to wortmannin / positive regulation of cell fate specification / regulation of cell migration involved in sprouting angiogenesis / positive regulation of lens fiber cell differentiation / positive regulation of endothelial cell chemotaxis to fibroblast growth factor / TGFBR3 regulates FGF2 signaling ...growth factor dependent regulation of skeletal muscle satellite cell proliferation / positive regulation of inner ear auditory receptor cell differentiation / positive regulation of neuroepithelial cell differentiation / regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / response to wortmannin / positive regulation of cell fate specification / regulation of cell migration involved in sprouting angiogenesis / positive regulation of lens fiber cell differentiation / positive regulation of endothelial cell chemotaxis to fibroblast growth factor / TGFBR3 regulates FGF2 signaling / regulation of retinal cell programmed cell death / Formation of intermediate mesoderm / FGFRL1 modulation of FGFR1 signaling / corticotropin hormone secreting cell differentiation / thyroid-stimulating hormone-secreting cell differentiation / Signaling by FGFR2 amplification mutants / Signaling by FGFR2 fusions / fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell / fibroblast growth factor receptor signaling pathway involved in hemopoiesis / fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow / lateral sprouting from an epithelium / fibroblast growth factor receptor signaling pathway involved in mammary gland specification / mammary gland bud formation / branch elongation involved in salivary gland morphogenesis / mesenchymal cell differentiation involved in lung development / lacrimal gland development / prostate gland morphogenesis / chondroblast differentiation / otic vesicle formation / lymphatic endothelial cell migration / regulation of smooth muscle cell differentiation / regulation of morphogenesis of a branching structure / negative regulation of fibroblast growth factor receptor signaling pathway / chemokine binding / orbitofrontal cortex development / POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation / squamous basal epithelial stem cell differentiation involved in prostate gland acinus development / embryonic organ morphogenesis / branching morphogenesis of a nerve / endochondral bone growth / morphogenesis of embryonic epithelium / bud elongation involved in lung branching / epidermis morphogenesis / positive regulation of epithelial cell proliferation involved in lung morphogenesis / angiogenesis involved in coronary vascular morphogenesis / reproductive structure development / Formation of the nephric duct / limb bud formation / positive regulation of epithelial tube formation / stem cell development / regulation of endothelial cell chemotaxis to fibroblast growth factor / positive regulation of cerebellar granule cell precursor proliferation / membranous septum morphogenesis / gland morphogenesis / fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development / ventricular zone neuroblast division / hyaluronan catabolic process / inner ear auditory receptor cell differentiation / negative regulation of wound healing / embryonic digestive tract morphogenesis / mesenchymal cell differentiation / positive regulation of phospholipase activity / Signaling by activated point mutants of FGFR3 / FGFR3c ligand binding and activation / positive regulation of stem cell differentiation / receptor-receptor interaction / epithelial cell proliferation involved in salivary gland morphogenesis / Phospholipase C-mediated cascade; FGFR3 / mesenchymal cell proliferation involved in lung development / cerebellar granule cell precursor proliferation / branching involved in prostate gland morphogenesis / FGFR2b ligand binding and activation / fibroblast growth factor receptor binding / branching involved in labyrinthine layer morphogenesis / lung lobe morphogenesis / embryonic morphogenesis / FGFR2c ligand binding and activation / Activated point mutants of FGFR2 / Phospholipase C-mediated cascade; FGFR2 / FGFR4 ligand binding and activation / regulation of osteoblast proliferation / behavioral response to ethanol / FGFR1b ligand binding and activation / mammary gland epithelial cell differentiation / Phospholipase C-mediated cascade; FGFR4 / glial cell differentiation / Signaling by activated point mutants of FGFR1 / fibroblast growth factor receptor activity / FGFR1c ligand binding and activation / organ induction / Downstream signaling of activated FGFR1 / branching involved in salivary gland morphogenesis / Phospholipase C-mediated cascade: FGFR1 / embryonic pattern specification / pyramidal neuron development / embryonic cranial skeleton morphogenesis / lung-associated mesenchyme development / paracrine signaling / Developmental Lineage of Pancreatic Acinar Cells / embryo development ending in birth or egg hatching 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.3 Å | ||||||
データ登録者 | Ibrahimi, O.A. / Eliseenkova, A.V. / Plotnikov, A.N. / Ornitz, D.M. / Mohammadi, M. | ||||||
引用 | ジャーナル: Proc.Natl.Acad.Sci.USA / 年: 2001タイトル: Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. 著者: Ibrahimi, O.A. / Eliseenkova, A.V. / Plotnikov, A.N. / Yu, K. / Ornitz, D.M. / Mohammadi, M. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 1iil.cif.gz | 270 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb1iil.ent.gz | 217.2 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 1iil.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 1iil_validation.pdf.gz | 412.7 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 1iil_full_validation.pdf.gz | 439 KB | 表示 | |
| XML形式データ | 1iil_validation.xml.gz | 27.9 KB | 表示 | |
| CIF形式データ | 1iil_validation.cif.gz | 43.6 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ii/1iil ftp://data.pdbj.org/pub/pdb/validation_reports/ii/1iil | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 | ![]()
| ||||||||
| 4 | ![]()
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 17249.732 Da / 分子数: 4 / 変異: C78S,C96S / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / プラスミド: pET-28a / 生物種 (発現宿主): Escherichia coli / 発現宿主: ![]() #2: タンパク質 | 分子量: 24701.012 Da / 分子数: 4 Fragment: EXTRACELLULAR LIGAND BINDING DOMAIN CONSISTING OF IG-LIKE DOMAINS II (D2) AND III (D3), RESIDUES 147-366 変異: P253R / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / プラスミド: pET-28a / 生物種 (発現宿主): Escherichia coli / 発現宿主: ![]() #3: 水 | ChemComp-HOH / | Has protein modification | Y | |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.75 Å3/Da / 溶媒含有率: 55.25 % | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7.5 詳細: PEG 4000, Isopropanol, HEPES-NaOH, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K | ||||||||||||||||||||||||||||||||||||||||||
| 結晶 | *PLUS 溶媒含有率: 58 % | ||||||||||||||||||||||||||||||||||||||||||
| 結晶化 | *PLUS 手法: 蒸気拡散法 | ||||||||||||||||||||||||||||||||||||||||||
| 溶液の組成 | *PLUS
|
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: NSLS / ビームライン: X4A / 波長: 0.97624 Å |
| 検出器 | タイプ: ADSC QUANTUM 4 / 検出器: CCD / 日付: 2000年10月7日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 0.97624 Å / 相対比: 1 |
| 反射 | 解像度: 2.3→30 Å / Num. all: 321836 / Num. obs: 321836 / % possible obs: 97.8 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 3.77 % / Rmerge(I) obs: 0.041 / Net I/σ(I): 26.1 |
| 反射 シェル | 解像度: 2.3→2.38 Å / Rmerge(I) obs: 0.137 / % possible all: 95.9 |
| 反射 | *PLUS Num. obs: 85442 / Num. measured all: 321836 |
| 反射 シェル | *PLUS % possible obs: 95.9 % |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: PDB ENTRY 1EV2 解像度: 2.3→25 Å / 交差検証法: THROUGHOUT / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | 溶媒モデル: CNS / Bsol: 32.5 Å2 / ksol: 0.352 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 2.3→25 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ソフトウェア | *PLUS 名称: CNS / 分類: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 | *PLUS 最高解像度: 2.3 Å / 最低解像度: 25 Å / σ(F): 0 / % reflection Rfree: 4.8 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 | *PLUS
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用











PDBj
















